Thank you very much.
My next question is for you, Mr. Bishop. You said that there is a conflict of interest when pharmaceutical companies are selling both anti-addiction treatments and addictive drugs. I also think that is a conflict of interest.
Do you have any recommendations to make in that regard? Do you feel there should be regulation or laws about this? Should pharmaceutical companies be prohibited from selling one or the other of those products? What measures should the federal government take?